Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Chemotherapy-Induced Peripheral Neuropathy
NCT00068445Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Cancer and Leukemia Group B. Started Feb 2004; status: completed.
02
Drugs
lamotrigine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT00068445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068445.